Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study-Reference-Cited by-同舟云学术

Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study

Published:2017-02-03 Issue:1 Volume:36 Page:44-48
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Ricciuti Giuseppina¹^ORCID,Finolezzi Erica¹,Luciani Stefania¹,Ranucci Elena¹,Federico Massimo²,Di Nicola Marta³,Zecca Isaia Antonio Luca³,Angrilli Francesco¹

Affiliation:

1. Center for the Diagnosis and Treatment of Lymphomas, Department of Hematology, Transfusion Medicine and Biotechnology; Spirito Santo Hospital; Pescara Italy

2. University of Modena and Reggio Emilia; Modena Italy

3. Department of Medical, Oral and Biotechnological Sciences; “G. D'Annunzio” University; Chieti Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference36 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2013

2. Cancer statistics;CA Cancer J Clin,2007a

3. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma;N Engl J Med,1993

4. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;N Engl J Med,2002a

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma;Blood Advances;2023-08-01

2. Impact of relative dose intensity of R-CCOP regimen in elderly patients with diffuse large B-cell lymphoma in China;Journal of the Formosan Medical Association;2022-12

3. A Comparison of Clinical Prognostic Indices in Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with a Pegylated Liposomal Doxorubicin Combination Regimen in China;Cancer Management and Research;2022-09

4. Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis;Critical Reviews in Oncology/Hematology;2021-07

5. Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment – A systematic review;Critical Reviews in Oncology/Hematology;2021-04